Dear Editor,Predicting a patient's response to cancer therapies and identifying additional molecular targets is crucial for advancing cancer treatment.BRAFvoe-specific inhibitors have demonstrated promising initia...Dear Editor,Predicting a patient's response to cancer therapies and identifying additional molecular targets is crucial for advancing cancer treatment.BRAFvoe-specific inhibitors have demonstrated promising initial clinical results in solid tumors;however,side effects and drug resistance are common,and for most patients,response to BRAFvoot inhibitor therapy is transient.展开更多
文摘Dear Editor,Predicting a patient's response to cancer therapies and identifying additional molecular targets is crucial for advancing cancer treatment.BRAFvoe-specific inhibitors have demonstrated promising initial clinical results in solid tumors;however,side effects and drug resistance are common,and for most patients,response to BRAFvoot inhibitor therapy is transient.
